Analysis of select members of the E26 (ETS) transcription factors family in colorectal cancer

Virchows Archiv

Volumn 458, Issue 4, 2011, Pages 421-430

  Deves, Candida ^a   Renck, Daiana ^a   Garicochea, Bernardo ^a   Da Silva, Vinicius Duval ^a   Giulianni Lopes, Tiago ^a   Fillman, Henrique ^a   Fillman, Lucio ^a   Lunardini, Silvana ^a   Basso, Luis Augusto ^a   Santos, Diogenes Santiago ^a   Batista Jr , Eraldo L ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Colorectal cancer; ETS transcription factors; Markers of tumor progression; Quantitative expression of biomarkers

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E26; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION; TUMOR BIOPSY; UPREGULATION;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-ETS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 79956219434     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-011-1053-6     Document Type: Article

References (36)

1. Sharrocks AD, Brown AL, Ling Y, Yates PR (1997) The ETS-domain transcription factor family. Int J Biochem Cell Biol 29 (12):1371-1387 (Pubitemid 28153488)
2. Shindoh M, Higashino F, Kaya M, Yasuda M, Funaoka K, Hanzawa M, Hida K, Kohgo T, Amemiya A, Yoshida K, Fujinaga K (1996) Correlated expression of matrix metalloproteinases and ETS family transcription factor e1a-f in invasive oral squamous-cell-carcinoma-derived cell lines. Am J Pathol 148(3):693-700 (Pubitemid 126660661)
3. Graves BJ, Petersen JM (1998) Specificity within the ETS family of transcription factors. Adv Cancer Res 75:1-55 (Pubitemid 28429032)
4. Degnan BM, Degnan SM, Naganuma T, Morse DE (1993) The ETS multigene family is conserved throughout the metazoa. Nucleic Acids Res 21(15):3479-3484 (Pubitemid 23241482)
5. Dittmer J (2003) The biology of the ETS1 proto-oncogene. Mol Cancer 2:29
6. Hollenhorst PC, Jones DA, Graves BJ (2004) Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res 32(18):5693-5702 (Pubitemid 39545685)
7. Li R, Pei H, Watson DK (2000) Regulation of ETS function by protein-protein interactions. Oncogene 19(55):6514-6523 (Pubitemid 32108441)
8. Sementchenko VI, Watson DK (2000) ETS target genes: past, present and future. Oncogene 19(55):6533-6548 (Pubitemid 32108443)
9. Seth A, Watson DK (2005) ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 41(16):2462-2478 (Pubitemid 41540623)
10. Hsu T, Trojanowska M, Watson DK (2004) ETS proteins in biological control and cancer. J Cell Biochem 91(5):896-903
11. Oikawa T, Yamada T (2003) Molecular biology of the ETS family of transcription factors. Gene 303:11-34 (Pubitemid 36151767)
12. Sharrocks AD (2001) The ETS-domain transcription factor family. Nat Rev Mol Cell Biol 2(11):827-837
13. Jedlicka P, Gutierrez-Hartmann A (2008) ETS transcription factors in intestinal morphogenesis, homeostasis and disease. Histol Histopathol 23(11):1417-1424
14. Turner DP, Findlay VJ, Moussa O, Watson DK (2007) Defining ETS transcription regulatory networks and their contribution to breast cancer progression. J Cell Biochem 102(3):549-559 (Pubitemid 47557410)
15. Andersen CL, Jensen JL, Orntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sETS. Cancer Res 64(15):5245-5250 (Pubitemid 39006544)
16. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta c(t)) method. Methods 25(4):402-408 (Pubitemid 34164012)
17. Sobin LH, Wittekind C (2002) TNM classification of malignant tumors, 6th edn. Wiley, Washington
18. Boedefeld WM 2nd, Soong R, Weiss H, Diasio RB, Urist MM, Bland KI, Heslin MJ (2005) E1a-f is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7. Mol Carcinog 43(1):13-17 (Pubitemid 40629198)
19. Moss AC, Lawlor G, Murray D, Tighe D, Madden SF, Mulligan AM, Keane CO, Brady HR, Doran PP, MacMathuna P (2006) Etv4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion. Biochem Biophys Res Commun 345 (1):216-221
20. Adachi Y, Yamamoto H, Itoh F, Arimura Y, Nishi M, Endo T, Imai K (2001) Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int J Cancer 95(5):290-294 (Pubitemid 32847038)
21. Horiuchi S, Yamamoto H, Min Y, Adachi Y, Itoh F, Imai K (2003) Association of ETS-related transcriptional factor e1af expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer. J Pathol 200(5):568-576 (Pubitemid 36987305)
22. Howe LR, Crawford HC, Subbaramaiah K, Hassell JA, Dannenberg AJ, Brown AM (2001) Pea3 is up-regulated in response to wnt1 and activates the expression of cyclooxygenase-2. J Biol Chem 276 (23):20108-20115
23. Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89 (17):1260-1270
24. Nosho K, Yoshida M, Yamamoto H, Taniguchi H, Adachi Y, Mikami M, Hinoda Y, Imai K (2005) Association of ETS-related transcriptional factor e1af expression with overexpression of matrix metalloproteinases, COX-2 and INOS in the early stage of colorectal carcinogenesis. Carcinogenesis 26(5):892-899
25. Chang CH, Scott GK, Kuo WL, Xiong X, Suzdaltseva Y, Park JW, Sayre P, Erny K, Collins C, Gray JW, Benz CC (1997) Esx: a structurally unique ETS overexpressed early during human breast tumorigenesis. Oncogene 14(13):1617-1622 (Pubitemid 27182846)
26. Sapi E, Flick MB, Rodov S, Kacinski BM (1998) ETS-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by bt20 breast carcinoma cells. Cancer Res 58(5):1027-1033 (Pubitemid 28182474)
27. Maruta S, Sakai H, Kanda S, Hayashi T, Kanetake H, Miyata Y (2009) E1af expression is associated with extra-prostatic growth and matrix metalloproteinase-7 expression in prostate cancer. APMIS 117(11):791-796
28. Feldman RJ, Sementchenko VI, Gayed M, Fraig MM, Watson DK (2003) PDEF expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res 63 (15):4626-4631 (Pubitemid 36951040)
29. Nozawa M, Yomogida K, Kanno N, Nonomura N, Miki T, Okuyama A, Nishimune Y, Nozaki M (2000) Prostate-specific transcription factor hPSE is translated only in normal prostate epithelial cells. Cancer Res 60(5):1348-1352 (Pubitemid 30152005)
30. Johnson TR, Koul S, Kumar B, Khandrika L, Venezia S, Maroni PD, Meacham RB, Koul HK (2010) Loss of PDEF, a prostate-derived ETS factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF. Mol Cancer 9:148
31. Anderson MK, Hernandez-Hoyos G, Diamond RA, Rothenberg EV (1999) Precise developmental regulation of ETS family transcription factors during specification and commitment to the T cell lineage. Development 126(14):3131-3148 (Pubitemid 29378177)
32. Gallant S, Gilkeson G (2006) ETS transcription factors and regulation of immunity. Arch Immunol Ther Exp Warsz 54 (3):149-163 (Pubitemid 44257335)
33. Bartholdy B, Du Roure C, Bordon A, Emslie D, Corcoran LM, Matthias P (2006) The ETS factor Spi-b is a direct critical target of the coactivator OBF-1. Proc Natl Acad Sci USA 103 (31):11665-11670 (Pubitemid 44182508)
34. Niini T, Vettenranta K, Hollmen J, Larramendy ML, Aalto Y, Wikman H, Nagy B, Seppanen JK, Ferrer Salvador A, Mannila H, Saarinen-Pihkala UM, Knuutila S (2002) Expression of myeloid-specific genes in childhood acute lymphoblastic leukemia - a cDNA array study. Leukemia 16(11):2213-2221 (Pubitemid 35331836)
35. Talby L, Chambost H, Roubaud MC, N'Guyen C, Milili M, Loriod B, Fossat C, Picard C, Gabert J, Chiappetta P, Michel G, Schiff C (2006) The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, Spi-b and BCR genes. Leuk Res 30(6):665-676
36. Nagy M, Chapuis B, Matthes T (2002) Expression of transcription factors pu.1, Spi-b, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells. Br J Haematol 116 (2):429-435 (Pubitemid 34155518)